ID   FEN1_HUMAN              Reviewed;         380 AA.
AC   P39748;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   22-JUL-2015, entry version 156.
DE   RecName: Full=Flap endonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE            Short=FEN-1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE            EC=3.1.-.- {ECO:0000255|HAMAP-Rule:MF_03140};
DE   AltName: Full=DNase IV;
DE   AltName: Full=Flap structure-specific endonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE   AltName: Full=Maturation factor 1;
DE            Short=MF1;
DE            Short=hFEN-1;
GN   Name=FEN1 {ECO:0000255|HAMAP-Rule:MF_03140}; Synonyms=RAD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8007985;
RA   Murray J.M., Tavassoli M., Al-Harithy R., Sheldrick K.S.,
RA   Lehmann A.R., Carr A.M., Watts F.Z.;
RT   "Structural and functional conservation of the human homolog of the
RT   Schizosaccharomyces pombe rad2 gene, which is required for chromosome
RT   segregation and recovery from DNA damage.";
RL   Mol. Cell. Biol. 14:4878-4888(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=7774922; DOI=10.1016/0888-7543(95)80129-A;
RA   Hiraoka L.R., Harrington J.J., Gerhard D.S., Lieber M.R., Hsieh C.-L.;
RT   "Sequence of human FEN-1, a structure-specific endonuclease, and
RT   chromosomal localization of the gene (FEN1) in mouse and human.";
RL   Genomics 25:220-225(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=7961795;
RA   Robins P., Pappin D.J.C., Wood R.D., Lindahl T.;
RT   "Structural and functional homology between mammalian DNase IV and the
RT   5'-nuclease domain of Escherichia coli DNA polymerase I.";
RL   J. Biol. Chem. 269:28535-28538(1994).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE-BINDING SITES, AND MUTAGENESIS
RP   OF ASP-34; ASP-86; ARG-103; GLU-158; ASP-179; ASP-181; GLY-231 AND
RP   ASP-233.
RX   PubMed=8621570; DOI=10.1074/jbc.271.16.9173;
RA   Shen B., Nolan J.P., Sklar L.A., Park M.S.;
RT   "Essential amino acids for substrate binding and catalysis of human
RT   flap endonuclease 1.";
RL   J. Biol. Chem. 271:9173-9176(1996).
RN   [8]
RP   INTERACTION WITH PCNA.
RX   PubMed=9305916; DOI=10.1074/jbc.272.39.24522;
RA   Gary R., Ludwig D.L., Cornelius H.L., MacInnes M.A., Park M.S.;
RT   "The DNA repair endonuclease XPG binds to proliferating cell nuclear
RT   antigen (PCNA) and shares sequence elements with the PCNA-binding
RT   regions of FEN-1 and cyclin-dependent kinase inhibitor p21.";
RL   J. Biol. Chem. 272:24522-24529(1997).
RN   [9]
RP   FUNCTION.
RX   PubMed=10744741; DOI=10.1074/jbc.275.14.10498;
RA   Tom S., Henricksen L.A., Bambara R.A.;
RT   "Mechanism whereby proliferating cell nuclear antigen stimulates flap
RT   endonuclease 1.";
RL   J. Biol. Chem. 275:10498-10505(2000).
RN   [10]
RP   INTERACTION WITH P300, AND ACETYLATION AT LYS-354; LYS-375; LYS-377
RP   AND LYS-380.
RX   PubMed=11430825; DOI=10.1016/S1097-2765(01)00272-6;
RA   Hasan S., Stucki M., Hassa P.O., Imhof R., Gehrig P., Hunziker P.,
RA   Hubscher U., Hottiger M.O.;
RT   "Regulation of human flap endonuclease-1 activity by acetylation
RT   through the transcriptional coactivator p300.";
RL   Mol. Cell 7:1221-1231(2001).
RN   [11]
RP   FUNCTION, SUBSTRATE-BINDING SITES ARG-47 AND ARG-70, AND MUTAGENESIS
RP   OF ARG-29; ARG-47; ARG-70; ARG-73 AND LYS-80.
RX   PubMed=11986308; DOI=10.1074/jbc.M111941200;
RA   Qiu J., Bimston D.N., Partikian A., Shen B.;
RT   "Arginine residues 47 and 70 of human flap endonuclease-1 are involved
RT   in DNA substrate interactions and cleavage site determination.";
RL   J. Biol. Chem. 277:24659-24666(2002).
RN   [12]
RP   INTERACTION WITH DDX11.
RX   PubMed=18499658; DOI=10.1074/jbc.M802696200;
RA   Farina A., Shin J.H., Kim D.H., Bermudez V.P., Kelman Z., Seo Y.S.,
RA   Hurwitz J.;
RT   "Studies with the human cohesin establishment factor, ChlR1.
RT   Association of ChlR1 with Ctf18-RFC and Fen1.";
RL   J. Biol. Chem. 283:20925-20936(2008).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND MUTAGENESIS OF
RP   SER-187.
RX   PubMed=18443037; DOI=10.1128/MCB.00200-08;
RA   Guo Z., Qian L., Liu R., Dai H., Zhou M., Zheng L., Shen B.;
RT   "Nucleolar localization and dynamic roles of flap endonuclease 1 in
RT   ribosomal DNA replication and damage repair.";
RL   Mol. Cell. Biol. 28:4310-4319(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-80 AND LYS-375, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   FUNCTION, MUTAGENESIS OF ARG-192, METHYLATION AT ARG-19; ARG-100;
RP   ARG-104 AND ARG-192, AND PHOSPHORYLATION AT SER-187.
RX   PubMed=20729856; DOI=10.1038/nchembio.422;
RA   Guo Z., Zheng L., Xu H., Dai H., Zhou M., Pascua M.R., Chen Q.M.,
RA   Shen B.;
RT   "Methylation of FEN1 suppresses nearby phosphorylation and facilitates
RT   PCNA binding.";
RL   Nat. Chem. Biol. 6:766-773(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197 AND THR-364, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   ALTERNATIVE INITIATION (ISOFORM FENMIT), AND SUBCELLULAR LOCATION
RP   (ISOFORM FENMIT).
RX   PubMed=23675412; DOI=10.1371/journal.pone.0062340;
RA   Kazak L., Reyes A., He J., Wood S.R., Brea-Calvo G., Holen T.T.,
RA   Holt I.J.;
RT   "A cryptic targeting signal creates a mitochondrial FEN1 isoform with
RT   tailed R-loop binding properties.";
RL   PLoS ONE 8:E62340-E62340(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.88 ANGSTROMS) OF 331-350.
RX   PubMed=15576034; DOI=10.1016/j.str.2004.09.018;
RA   Bruning J.B., Shamoo Y.;
RT   "Structural and thermodynamic analysis of human PCNA with peptides
RT   derived from DNA polymerase-delta p66 subunit and flap endonuclease-
RT   1.";
RL   Structure 12:2209-2219(2004).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 2-380 IN COMPLEX WITH PCNA.
RX   PubMed=15616578; DOI=10.1038/sj.emboj.7600519;
RA   Sakurai S., Kitano K., Yamaguchi H., Hamada K., Okada K., Fukuda K.,
RA   Uchida M., Ohtsuka E., Morioka H., Hakoshima T.;
RT   "Structural basis for recruitment of human flap endonuclease 1 to
RT   PCNA.";
RL   EMBO J. 24:683-693(2005).
CC   -!- FUNCTION: Structure-specific nuclease with 5'-flap endonuclease
CC       and 5'-3' exonuclease activities involved in DNA replication and
CC       repair. During DNA replication, cleaves the 5'-overhanging flap
CC       structure that is generated by displacement synthesis when DNA
CC       polymerase encounters the 5'-end of a downstream Okazaki fragment.
CC       It enters the flap from the 5'-end and then tracks to cleave the
CC       flap base, leaving a nick for ligation. Also involved in the long
CC       patch base excision repair (LP-BER) pathway, by cleaving within
CC       the apurinic/apyrimidinic (AP) site-terminated flap. Acts as a
CC       genome stabilization factor that prevents flaps from equilibrating
CC       into structurs that lead to duplications and deletions. Also
CC       possesses 5'-3' exonuclease activity on nicked or gapped double-
CC       stranded DNA, and exhibits RNase H activity. Also involved in
CC       replication and repair of rDNA and in repairing mitochondrial DNA.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:10744741,
CC       ECO:0000269|PubMed:11986308, ECO:0000269|PubMed:18443037,
CC       ECO:0000269|PubMed:20729856, ECO:0000269|PubMed:7961795,
CC       ECO:0000269|PubMed:8621570}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 2 magnesium ions per subunit. They probably participate
CC       in the reaction catalyzed by the enzyme. May bind an additional
CC       third magnesium ion after substrate binding.;
CC   -!- SUBUNIT: Interacts with PCNA. Three molecules of FEN1 bind to one
CC       PCNA trimer with each molecule binding to one PCNA monomer. PCNA
CC       stimulates the nuclease activity without altering cleavage
CC       specificity. The C-terminal domain binds EP300. Can bind
CC       simultaneously to both PCNA and EP300. Interacts with DDX11.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:11430825,
CC       ECO:0000269|PubMed:15616578, ECO:0000269|PubMed:18499658,
CC       ECO:0000269|PubMed:9305916}.
CC   -!- INTERACTION:
CC       P54132:BLM; NbExp=4; IntAct=EBI-707816, EBI-621372;
CC       Q96NY9:MUS81; NbExp=5; IntAct=EBI-707816, EBI-2370806;
CC       P12004:PCNA; NbExp=4; IntAct=EBI-707816, EBI-358311;
CC       Q14191:WRN; NbExp=9; IntAct=EBI-707816, EBI-368417;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus, nucleolus. Nucleus,
CC       nucleoplasm. Note=Resides mostly in the nucleoli and relocalizes
CC       to the nucleoplasm upon DNA damage.
CC   -!- SUBCELLULAR LOCATION: Isoform FENMIT: Mitochondrion
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:23675412}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1;
CC         IsoId=P39748-1; Sequence=Displayed;
CC       Name=FENMIT;
CC         IsoId=P39748-2; Sequence=VSP_047520;
CC         Note=No nuclease activity. Binds preferentially to RNA flap
CC         structures and R-loops.;
CC   -!- PTM: Acetylated by EP300. Acetylation inhibits both endonuclease
CC       and exonuclease activity. Acetylation also reduces DNA-binding
CC       activity but does not affect interaction with PCNA or EP300.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:11430825}.
CC   -!- PTM: Phosphorylation upon DNA damage induces relocalization to the
CC       nuclear plasma. Phosphorylation at Ser-187 by CDK2 occurs during
CC       late S-phase and results in dissociation from PCNA.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:20729856}.
CC   -!- PTM: Methylation at Arg-192 by PRMT5 impedes Ser-187
CC       phosphorylation and increases interaction with PCNA.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:20729856}.
CC   -!- SIMILARITY: Belongs to the XPG/RAD2 endonuclease family. FEN1
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_03140}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/fen1/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FEN1ID40543ch11q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X76771; CAA54166.1; -; mRNA.
DR   EMBL; L37374; AAA91331.1; -; mRNA.
DR   EMBL; AF523117; AAM74238.1; -; Genomic_DNA.
DR   EMBL; AC004770; AAC23394.1; -; Genomic_DNA.
DR   EMBL; BC000323; AAH00323.1; -; mRNA.
DR   CCDS; CCDS8010.1; -. [P39748-1]
DR   PIR; A56531; A56531.
DR   RefSeq; NP_004102.1; NM_004111.5. [P39748-1]
DR   UniGene; Hs.409065; -.
DR   PDB; 1U7B; X-ray; 1.88 A; B=331-350.
DR   PDB; 1UL1; X-ray; 2.90 A; X/Y/Z=2-380.
DR   PDB; 3Q8K; X-ray; 2.20 A; A=2-336.
DR   PDB; 3Q8L; X-ray; 2.32 A; A=2-336.
DR   PDB; 3Q8M; X-ray; 2.60 A; A/B=2-336.
DR   PDB; 3UVU; X-ray; 2.38 A; B=352-370.
DR   PDBsum; 1U7B; -.
DR   PDBsum; 1UL1; -.
DR   PDBsum; 3Q8K; -.
DR   PDBsum; 3Q8L; -.
DR   PDBsum; 3Q8M; -.
DR   PDBsum; 3UVU; -.
DR   ProteinModelPortal; P39748; -.
DR   SMR; P39748; 2-336.
DR   BioGrid; 108528; 44.
DR   DIP; DIP-24216N; -.
DR   IntAct; P39748; 15.
DR   MINT; MINT-5004212; -.
DR   STRING; 9606.ENSP00000305480; -.
DR   BindingDB; P39748; -.
DR   ChEMBL; CHEMBL5027; -.
DR   PhosphoSite; P39748; -.
DR   BioMuta; FEN1; -.
DR   DMDM; 729475; -.
DR   MaxQB; P39748; -.
DR   PaxDb; P39748; -.
DR   PeptideAtlas; P39748; -.
DR   PRIDE; P39748; -.
DR   DNASU; 2237; -.
DR   Ensembl; ENST00000305885; ENSP00000305480; ENSG00000168496.
DR   GeneID; 2237; -.
DR   KEGG; hsa:2237; -.
DR   UCSC; uc001nsg.3; human. [P39748-1]
DR   CTD; 2237; -.
DR   GeneCards; GC11P061560; -.
DR   HGNC; HGNC:3650; FEN1.
DR   HPA; CAB002262; -.
DR   HPA; HPA006581; -.
DR   HPA; HPA006748; -.
DR   MIM; 600393; gene.
DR   neXtProt; NX_P39748; -.
DR   PharmGKB; PA28090; -.
DR   eggNOG; COG0258; -.
DR   GeneTree; ENSGT00640000091478; -.
DR   HOGENOM; HOG000193853; -.
DR   HOVERGEN; HBG000844; -.
DR   InParanoid; P39748; -.
DR   KO; K04799; -.
DR   OMA; GSQDYDS; -.
DR   OrthoDB; EOG72JWHG; -.
DR   PhylomeDB; P39748; -.
DR   TreeFam; TF105701; -.
DR   Reactome; REACT_2192; POLB-Dependent Long Patch Base Excision Repair.
DR   Reactome; REACT_355510; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; REACT_70; Removal of the Flap Intermediate.
DR   Reactome; REACT_7999; Removal of the Flap Intermediate from the C-strand.
DR   SignaLink; P39748; -.
DR   ChiTaRS; FEN1; human.
DR   EvolutionaryTrace; P39748; -.
DR   GeneWiki; Flap_structure-specific_endonuclease_1; -.
DR   GenomeRNAi; 2237; -.
DR   NextBio; 9055; -.
DR   PRO; PR:P39748; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; P39748; -.
DR   CleanEx; HS_FEN1; -.
DR   ExpressionAtlas; P39748; baseline and differential.
DR   Genevisible; P39748; HS.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; IDA:UniProtKB.
DR   GO; GO:0017108; F:5'-flap endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; IMP:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; TAS:ProtInc.
DR   GO; GO:0008309; F:double-stranded DNA exodeoxyribonuclease activity; TAS:ProtInc.
DR   GO; GO:0004519; F:endonuclease activity; TAS:ProtInc.
DR   GO; GO:0004527; F:exonuclease activity; TAS:ProtInc.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0030145; F:manganese ion binding; IEA:Ensembl.
DR   GO; GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; TAS:Reactome.
DR   GO; GO:0006281; P:DNA repair; TAS:Reactome.
DR   GO; GO:0006260; P:DNA replication; TAS:ProtInc.
DR   GO; GO:0043137; P:DNA replication, removal of RNA primer; IDA:UniProtKB.
DR   GO; GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome.
DR   GO; GO:0006302; P:double-strand break repair; TAS:ProtInc.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0000278; P:mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC.
DR   GO; GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC.
DR   GO; GO:0000723; P:telomere maintenance; TAS:Reactome.
DR   GO; GO:0000722; P:telomere maintenance via recombination; TAS:Reactome.
DR   GO; GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome.
DR   GO; GO:0009650; P:UV protection; TAS:ProtInc.
DR   Gene3D; 3.40.50.1010; -; 1.
DR   HAMAP; MF_00614; Fen; 1.
DR   InterPro; IPR020045; 5-3_exonuclease_C.
DR   InterPro; IPR023426; Flap_endonuc.
DR   InterPro; IPR008918; HhH2.
DR   InterPro; IPR029060; PIN_domain-like.
DR   InterPro; IPR006086; XPG-I_dom.
DR   InterPro; IPR006084; XPG/Rad2.
DR   InterPro; IPR019974; XPG_CS.
DR   InterPro; IPR006085; XPG_DNA_repair_N.
DR   PANTHER; PTHR11081; PTHR11081; 1.
DR   Pfam; PF00867; XPG_I; 1.
DR   Pfam; PF00752; XPG_N; 1.
DR   PRINTS; PR00853; XPGRADSUPER.
DR   SMART; SM00279; HhH2; 1.
DR   SMART; SM00484; XPGI; 1.
DR   SMART; SM00485; XPGN; 1.
DR   SUPFAM; SSF47807; SSF47807; 1.
DR   SUPFAM; SSF88723; SSF88723; 1.
DR   PROSITE; PS00841; XPG_1; 1.
DR   PROSITE; PS00842; XPG_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Direct protein sequencing; DNA damage; DNA repair; DNA replication;
KW   Endonuclease; Exonuclease; Hydrolase; Magnesium; Metal-binding;
KW   Methylation; Mitochondrion; Nuclease; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    380       Flap endonuclease 1.
FT                                /FTId=PRO_0000154069.
FT   REGION        1    104       N-domain.
FT   REGION      122    253       I-domain.
FT   REGION      336    344       Interaction with PCNA.
FT   METAL        34     34       Magnesium 1.
FT   METAL        86     86       Magnesium 1.
FT   METAL       158    158       Magnesium 1.
FT   METAL       160    160       Magnesium 1.
FT   METAL       179    179       Magnesium 2.
FT   METAL       181    181       Magnesium 2.
FT   METAL       233    233       Magnesium 2.
FT   BINDING      47     47       DNA substrate.
FT   BINDING      70     70       DNA substrate.
FT   BINDING     158    158       DNA substrate.
FT   BINDING     231    231       DNA substrate.
FT   BINDING     233    233       DNA substrate.
FT   MOD_RES      19     19       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES      80     80       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19608861}.
FT   MOD_RES     100    100       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES     104    104       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES     187    187       Phosphoserine; by CDK2.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES     192    192       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES     197    197       Phosphoserine.
FT                                {ECO:0000269|PubMed:20068231}.
FT   MOD_RES     354    354       N6-acetyllysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_03140,
FT                                ECO:0000269|PubMed:11430825}.
FT   MOD_RES     364    364       Phosphothreonine.
FT                                {ECO:0000269|PubMed:20068231}.
FT   MOD_RES     375    375       N6-acetyllysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_03140,
FT                                ECO:0000269|PubMed:11430825,
FT                                ECO:0000269|PubMed:19608861}.
FT   MOD_RES     377    377       N6-acetyllysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_03140,
FT                                ECO:0000269|PubMed:11430825}.
FT   MOD_RES     380    380       N6-acetyllysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_03140,
FT                                ECO:0000269|PubMed:11430825}.
FT   VAR_SEQ       1     64       Missing (in isoform FENMIT).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_047520.
FT   MUTAGEN      29     29       R->A: No significant effect on
FT                                exonuclease activity or flap endonuclease
FT                                activity. {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      34     34       D->A: Loss of flap endonuclease activity
FT                                but substrate binding activity is
FT                                retained. {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN      47     47       R->A: Significantly reduced exonuclease
FT                                activity and reduced substrate binding.
FT                                The positions of the cleavage sites are
FT                                also shifted.
FT                                {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      70     70       R->A: Loss of exonuclease activity and
FT                                reduced endonuclease activity. Reduced
FT                                substrate binding.
FT                                {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      73     73       R->A: No significant effect on
FT                                exonuclease activity or flap endonuclease
FT                                activity. {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      80     80       K->A: No significant effect on
FT                                exonuclease activity or flap endonuclease
FT                                activity. {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      86     86       D->A: Loss of flap endonuclease activity
FT                                but substrate binding activity is
FT                                retained. {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     103    103       R->A: No effect on flap endonuclease
FT                                activity or substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     158    158       E->A: Loss of flap endonuclease activity
FT                                and substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     179    179       D->A: No effect on flap endonuclease
FT                                activity or substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     181    181       D->A: Loss of flap endonuclease activity
FT                                but substrate binding activity is
FT                                retained. {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     187    187       S->A: Fails to translocate from nucleoli
FT                                to the nuclear plasma.
FT                                {ECO:0000269|PubMed:18443037}.
FT   MUTAGEN     187    187       S->D: Diminishes nucleolar localization.
FT                                {ECO:0000269|PubMed:18443037}.
FT   MUTAGEN     192    192       R->K: Impairs ability to localize to
FT                                sites of DNA replication or repair.
FT                                {ECO:0000269|PubMed:20729856}.
FT   MUTAGEN     231    231       G->A: Loss of flap endonuclease activity
FT                                and substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     233    233       D->A: Loss of flap endonuclease activity
FT                                and substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   HELIX         6     13       {ECO:0000244|PDB:3Q8K}.
FT   HELIX        15     17       {ECO:0000244|PDB:3Q8K}.
FT   STRAND       18     22       {ECO:0000244|PDB:3Q8K}.
FT   HELIX        23     26       {ECO:0000244|PDB:3Q8K}.
FT   STRAND       30     34       {ECO:0000244|PDB:3Q8K}.
FT   HELIX        35     45       {ECO:0000244|PDB:3Q8K}.
FT   STRAND       47     52       {ECO:0000244|PDB:3Q8M}.
FT   HELIX        62     75       {ECO:0000244|PDB:3Q8K}.
FT   TURN         76     78       {ECO:0000244|PDB:3Q8K}.
FT   STRAND       80     85       {ECO:0000244|PDB:3Q8K}.
FT   HELIX        91     93       {ECO:0000244|PDB:3Q8K}.
FT   HELIX        94    115       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       120    129       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       135    148       {ECO:0000244|PDB:3Q8K}.
FT   STRAND      152    154       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       159    168       {ECO:0000244|PDB:3Q8K}.
FT   STRAND      171    176       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       181    184       {ECO:0000244|PDB:3Q8K}.
FT   STRAND      188    193       {ECO:0000244|PDB:3Q8K}.
FT   STRAND      203    208       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       209    216       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       220    230       {ECO:0000244|PDB:3Q8K}.
FT   STRAND      233    235       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       243    253       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       256    262       {ECO:0000244|PDB:3Q8K}.
FT   TURN        265    267       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       276    284       {ECO:0000244|PDB:3Q8K}.
FT   TURN        291    293       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       303    310       {ECO:0000244|PDB:3Q8K}.
FT   TURN        311    314       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       318    335       {ECO:0000244|PDB:3Q8K}.
FT   HELIX       340    342       {ECO:0000244|PDB:1U7B}.
FT   STRAND      344    351       {ECO:0000244|PDB:1UL1}.
SQ   SEQUENCE   380 AA;  42593 MW;  5154F2F6E57592C5 CRC64;
     MGIQGLAKLI ADVAPSAIRE NDIKSYFGRK VAIDASMSIY QFLIAVRQGG DVLQNEEGET
     TSHLMGMFYR TIRMMENGIK PVYVFDGKPP QLKSGELAKR SERRAEAEKQ LQQAQAAGAE
     QEVEKFTKRL VKVTKQHNDE CKHLLSLMGI PYLDAPSEAE ASCAALVKAG KVYAAATEDM
     DCLTFGSPVL MRHLTASEAK KLPIQEFHLS RILQELGLNQ EQFVDLCILL GSDYCESIRG
     IGPKRAVDLI QKHKSIEEIV RRLDPNKYPV PENWLHKEAH QLFLEPEVLD PESVELKWSE
     PNEEELIKFM CGEKQFSEER IRSGVKRLSK SRQGSTQGRL DDFFKVTGSL SSAKRKEPEP
     KGSTKKKAKT GAAGKFKRGK
//
